Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs. Part III

被引:8
|
作者
Rao, Pemmaraju N. [1 ]
Cessac, James W. [1 ]
Boyd, James W. [1 ]
Hanson, Arthur D. [2 ]
Shah, Jamshed [2 ]
机构
[1] SW Fdn Biomed Res, Dept Organ Chem, San Antonio, TX 78245 USA
[2] EntreMed Inc, Rockville, MD 20850 USA
关键词
estrogens; 2-methoxyestradiol; antiangiogenesis; antimitotic activity; antiproliferative activity;
D O I
10.1016/j.steroids.2007.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The syntheses and antimitotic activity of several novel analogs of 2-methoxyestradiol are described. Structural modifications include ring-D homologation, aromatization of the six-membered ring-D to a chrysine type molecule, and introduction of unsaturation in five-membered ring-D along with substitution of alkyl and ethynyl groups for the 17 beta-hydroxy function. of nine analogs synthesized, five have demonstrated superior antiproliferative activities compared to 2-methoxyestradiol. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 183
页数:13
相关论文
共 50 条
  • [31] Pharmacokinetic evaluation and antitumor activity of 2-methoxyestradiol nanosuspension
    Du, Shuzhang
    Zhu, Ling
    Du, Bin
    Shi, Xiufang
    Zhang, Zhenzhong
    Wang, Shuyu
    Zhang, Chaofeng
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2012, 38 (04) : 431 - 438
  • [32] Promising preclinical activity of 2-methoxyestradiol in multiple myeloma
    Dingli, D
    Timm, M
    Russell, SJ
    Witzig, TE
    Rajkumar, SV
    CLINICAL CANCER RESEARCH, 2002, 8 (12) : 3948 - 3954
  • [33] A simple and convenient synthesis of 2-methoxyestradiol from estrone
    Prakasham, A. P.
    Shanker, Karuna
    Negi, Arvind S.
    STEROIDS, 2012, 77 (05) : 467 - 470
  • [34] 2-Methoxyestradiol - A novel prognostic marker in malignant melanoma?
    Hrgovic, I.
    Kleemann, J.
    Doll, M.
    Loquai, C.
    Kaufmann, R.
    Meissner, M.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E24 - E24
  • [35] Synthesis and structure activity studies of a novel series of tricyclic benzazepine analogs.
    PayneGallimore, PA
    Frazee, WJ
    Brush, KA
    Pullan, LM
    Goldstein, JM
    Patel, JB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 35 - MEDI
  • [36] Synthesis and biotesting of new carrier prodrugs of 2-methoxyestradiol
    Lozinskaya, Natalia A.
    Maximova, Natalia A.
    Bazanov, Daniil R.
    Sosonyuk, Sergey E.
    Wobith, Birgit
    Zetirov, Nikolay A.
    Kharitonashvili, Elena V.
    Zefirova, Olga N.
    Kuznetsov, Sergey A.
    Proskurnina, Marina V.
    MENDELEEV COMMUNICATIONS, 2020, 30 (01) : 7 - 9
  • [37] A VERSATILE SYNTHESIS OF A NEW ANTICANCER METABOLITE, 2-METHOXYESTRADIOL
    HE, HM
    CUSHMAN, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 80 - MEDI
  • [38] Synthesis, antiproliferative, and pharmacokinetic properties of 3-and 17-double-modified analogs of 2-methoxyestradiol
    Agoston, Gregory E.
    Shah, Jamshed H.
    Suwandi, Lita
    Hanson, Arthur D.
    Zhan, Xiaoguo
    LaVallee, Theresa M.
    Pribluda, Victor
    Treston, Anthony M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6241 - 6244
  • [39] 2-methoxyestradiol and analogs as novel antiproliferative agents: Analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding
    Hughes, RA
    Harris, T
    Altmann, E
    McAllister, D
    Vlahos, R
    Robertson, A
    Cushman, M
    Wang, ZQ
    Stewart, AG
    MOLECULAR PHARMACOLOGY, 2002, 61 (05) : 1053 - 1069
  • [40] Synthesis and in vitro evaluation of novel camptothecin analogs.
    Penco, S
    Dallavalle, S
    Ferrari, A
    Merlini, L
    Zunino, F
    Perego, P
    Carenini, N
    Pisano, C
    Martinelli, R
    Bucci, F
    Castorina, M
    Tinti, O
    Marzi, M
    Carminati, P
    CLINICAL CANCER RESEARCH, 2000, 6 : 4531S - 4531S